This HTML5 document contains 182 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.3390/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92875750
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована 23 серпня 2019 article scientifique publié en 2019 im August 2019 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'agostu de 2019 wetenschappelijk artikel scientific article published on 23 August 2019 գիտական հոդված հրատարակված 2019 թվականի օգոստոսի 23-ին
p:P577
wds:Q92875750-A58B13CE-048B-4BE4-B214-25BB97424B6C
wdt:P577
2019-08-23T00:00:00Z
p:P2860
wds:Q92875750-AA3F3BF4-E174-4BD4-9DC6-883E7CC3FEB3 wds:Q92875750-AA850CE8-3182-4813-BF71-134F40206BC6 wds:Q92875750-AF2C6A40-71D4-4CD4-B9AF-E899E1AA8133 wds:Q92875750-B310CF04-36A0-4AFC-8BF6-D42F01D41EE0 wds:Q92875750-A0A869D5-1943-4876-9072-F253B6C87C3D wds:Q92875750-A13BF129-8A0A-4AFE-8560-C24C6B6A59C8 wds:Q92875750-A9A967C3-4432-4DAF-B4A9-118A3680E955 wds:Q92875750-BFBAB37E-E438-4018-92F4-E0A8393360C9 wds:Q92875750-BFE8CDBA-3E92-4A95-BBF5-345BF6F3A3B5 wds:Q92875750-C35147E9-7D2F-464B-A308-E1A64EC439BF wds:Q92875750-B59EC83E-5630-4A5E-85D2-6729BCE054BE wds:Q92875750-B996312B-AB3F-45DD-BC00-92F5A95096E3 wds:Q92875750-B997A16A-DE92-422B-A0E6-9EFDE8AAA559 wds:Q92875750-BE1B6B1B-4265-4361-BC60-D138D6AB6EA5 wds:Q92875750-CDEB2AAA-FE73-431B-ACBB-195A9AE87D65 wds:Q92875750-D8F2E9B6-9E3C-442B-A7CA-B6253C4FBE99 wds:Q92875750-DB976E73-38D6-4355-B590-71068B915C47 wds:Q92875750-C98A65E6-F31C-4A89-93D7-6B51A42EB519 wds:Q92875750-CB32C2B6-F865-417C-B20A-291728D36B26 wds:Q92875750-CDC26E9F-E93F-4945-AFBB-C05F682A2690 wds:Q92875750-EE2CC519-4AAD-4481-A967-3288D114F36B wds:Q92875750-EEA32EC0-9AFC-4AB9-8503-ED87FAE1B088 wds:Q92875750-F364AB82-8017-4E6D-AEB6-1A952E0B10AF wds:Q92875750-DDB180A7-A9D6-4ED7-AB84-3D98E18348E1 wds:Q92875750-E909E40C-E53A-4293-A93D-E6A5BF9D3A06 wds:Q92875750-FC35FCCA-26C5-4090-B3CC-E90E7B7A3624 wds:Q92875750-FF4FD69B-3DB0-4D78-AEDF-26C03C78CD66 wds:Q92875750-FF6A12FF-A214-4F49-A0B8-A3AE83545A7E wds:Q92875750-F4459D3C-E991-4571-B0D1-285970B6A910 wds:Q92875750-F67A8743-E283-4002-91DC-00EFEA9608D0 wds:Q92875750-FAE46E59-0573-4AC8-90A4-F6079F1CF306 wds:Q92875750-FB42E5F2-F78C-4071-B083-75F5CA64A44C wds:Q92875750-0041EC45-0B73-4D25-8BC3-E22613E39059 wds:Q92875750-03226B27-9679-45FC-9103-BE15CA8CA2C7 wds:Q92875750-079F232D-F978-46BF-845C-A666C8A7226E wds:Q92875750-1E2807C2-70C9-4E0A-B28A-BA369E866D65 wds:Q92875750-1EB1C838-7F6C-4886-8A48-1FC2585DDAD6 wds:Q92875750-1FB6674B-72C5-4274-AC31-B01AC4675E2A wds:Q92875750-126D78D6-805E-4739-B3BE-3898F59E0066 wds:Q92875750-1365DCF1-E8C4-4D98-BC89-1AABB8F1480F wds:Q92875750-3A44C765-C34E-4939-8150-FB375A791E05 wds:Q92875750-3E11BD9A-4FCF-408E-8057-64A449DD68C5 wds:Q92875750-2971FF0C-D75E-41CF-891F-2E7E99FB9496 wds:Q92875750-2C828065-BBE9-4C53-9EE1-4F8A25AE17DB wds:Q92875750-2F7A115C-F65A-48B0-BCEE-476AEDD18D19 wds:Q92875750-5714FE7F-65CD-4EFB-807B-0F6AD2B3748C wds:Q92875750-5CB4EF32-9EE1-49E9-83FD-23BE4CB75EE4 wds:Q92875750-5E53FF4E-60A8-447A-AC59-28D1E8DF6C5F wds:Q92875750-3FE768A8-46F0-46A6-B325-A44F3745FCC2 wds:Q92875750-40718F97-D684-430B-BF1E-8C91DAD50BCC wds:Q92875750-417DB854-32EE-4920-9FDB-9EA18FE83266 wds:Q92875750-69BFF2C2-FA83-4466-8B97-071808F3231E wds:Q92875750-6B6D8BC8-6A7D-4266-8495-C29DD5968608 wds:Q92875750-6C12CF2E-5DB0-48E0-9D6B-4D8410E98DBC wds:Q92875750-73D59228-5359-4EF0-82FA-89FC757F3BF3 wds:Q92875750-6477EE02-FE5E-4DE7-A790-F5EF2DF84705 wds:Q92875750-678861C9-CF78-40DE-8251-6664FB47AA18 wds:Q92875750-8AC9A6AB-8803-41E4-9F1A-323CBD60BE96 wds:Q92875750-9FF50A66-BC18-4B9E-B7AA-22213703B72F wds:Q92875750-77BF5768-C014-40ED-BFE2-D1DF4A76A384 wds:Q92875750-7A838E65-6772-4BFD-B570-F768BC05FEEA wds:Q92875750-7E6DD811-3757-4D0B-B189-962C23EC9158 wds:Q92875750-826F620D-7AE2-46BD-A096-FC33CFFBBDF7
wdt:P2860
wd:Q24245033 wd:Q38843204 wd:Q84160611 wd:Q39985612 wd:Q80180717 wd:Q79329846 wd:Q82657676 wd:Q57000195 wd:Q35068618 wd:Q46755956 wd:Q39206254 wd:Q42973721 wd:Q38115075 wd:Q41451555 wd:Q38366954 wd:Q38099727 wd:Q38166552 wd:Q34530993 wd:Q41601387 wd:Q38423920 wd:Q44217507 wd:Q73706623 wd:Q42021859 wd:Q37884663 wd:Q37006161 wd:Q35692281 wd:Q48015133 wd:Q80164114 wd:Q50733436 wd:Q38205873 wd:Q52887574 wd:Q46345854 wd:Q39339014 wd:Q37207716 wd:Q40813637 wd:Q38836966 wd:Q92925330 wd:Q88899916 wd:Q38888227 wd:Q38059422 wd:Q29616286 wd:Q39147818 wd:Q41825771 wd:Q38962353 wd:Q87143849 wd:Q24194313 wd:Q28360107 wd:Q57821505 wd:Q53143839 wd:Q37206536 wd:Q40899595 wd:Q38741563 wd:Q77374966 wd:Q34418894 wd:Q38196655 wd:Q34834632 wd:Q35857951 wd:Q82100199 wd:Q39131820 wd:Q47331694 wd:Q43553836 wd:Q43525998 wd:Q46374171
p:P2093
wds:Q92875750-FF5208D2-CE8F-4E52-9C1F-B3C28C343790 wds:Q92875750-64A5151D-00CD-47D5-B868-951847C68ABD wds:Q92875750-F18DB499-D2C7-4482-9E76-D4AE861D6FB8 wds:Q92875750-880AA85B-9D1D-459A-A7E1-CEE804977BA4 wds:Q92875750-C4FE4813-9287-4EFA-890D-945A0F247875
wdt:P2093
Bahez Gareb Pauline Koopmans Silke Posthumus Daan J Touw Jos G W Kosterink
rdfs:label
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process
skos:prefLabel
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process
schema:name
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process
p:P50
wds:Q92875750-12046711-4160-4218-9694-9650CC519CA4 wds:Q92875750-C53443BC-4D4E-4FC8-BAF3-F3DD3C746A02 wds:Q92875750-506B8FF3-8B2D-459E-B87A-C20C923DB048
wdt:P50
wd:Q63364127 wd:Q91224063 wd:Q90379218
p:P1476
wds:Q92875750-63B703F7-234C-43D5-8607-CF31DA71EAAA
wdt:P1476
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process
p:P31
wds:Q92875750-DFD9C284-02D0-45DA-92F6-17D1C0C6F251
wdt:P31
wd:Q13442814
p:P921
wds:Q92875750-1E26F630-395F-4DA2-B359-53D616BE3372
wdt:P921
wd:Q917447
p:P698
wds:Q92875750-34643232-8260-4DCC-BB22-4B64923AA2AF
wdtn:P698
n12:31450748
wdt:P698
31450748
p:P1433
wds:Q92875750-1BA28CCF-999F-4E3A-A6E9-D9564DA5CAE3
wdt:P1433
wd:Q27723332
p:P433
wds:Q92875750-3ECADB8A-90FC-42E7-B7C6-BA6EEB996081
p:P478
wds:Q92875750-D4919B90-D6D7-429A-8D86-FDE6413DBAD5
wdt:P433
9
wdt:P478
11
p:P356
wds:Q92875750-DE7B0404-6DD6-4E65-B078-BAF8CCFE3E99
wdtn:P356
n8:PHARMACEUTICS11090428
wdt:P356
10.3390/PHARMACEUTICS11090428
p:P275
wds:Q92875750-3185b69a-62fb-4b85-9d8e-bca1aa84aaf9
p:P6216
wds:Q92875750-8844fe17-3139-4d3a-b1e1-8244403f8cf0
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q92875750-2795EE43-9943-4B54-9303-7253007C8B3D
wdt:P932
6781063